Mixed options sentiment in Novo Nordisk (NVO), with shares down 40c near $36.01. Options volume roughly in line with average with 92k contracts traded and calls leading puts for a put/call ratio of 0.64, compared to a typical level near 0.7. Implied volatility (IV30) is higher by 0.1 points near 46.55,and above the 52wk median, suggesting an expected daily move of $1.06. Put-call skew flattened, suggesting a modestly bullish tone.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk’s EVOKE Plus Alzheimer’s Trial: What the Latest Update Means for NVO Investors
- HLTH, ESIH, HLT: Look to Europe for Healthcare ETFs
- Novo Nordisk Updates Articles of Association and Capital Increase Mandate
- Novo Nordisk Wins FDA Nod for First Once‑Weekly Basal Insulin Awiqli in U.S.
- Novo Nordisk says Awiql approved by FDA in type 2 diabetes patients
